Lentiviral delivery of short hairpin RNAs

Advanced Drug Delivery Reviews

Volumn 61, Issue 9, 2009, Pages 732-745

  Manjunath, N ^a   Wu, Haoquan ^a   Subramanya, Sandesh ^a   Shankar, Premlata ^a  

^a Paul L Foster School of Medicine   (United States)

Author keywords

Lentivirus; miRNA; RNAi; shRNA; Viral infection

Indexed keywords

LENTIVIRUS; MIRNA; RNAI; SHRNA; VIRAL INFECTION;

GENE EXPRESSION; GENETIC ENGINEERING; RNA; STRATEGIC PLANNING; TOXICITY;

NUCLEIC ACIDS;

LENTIVIRUS VECTOR; MICRORNA; SHORT HAIRPIN RNA;

ANTIVIRAL ACTIVITY; COXSACKIE VIRUS INFECTION; DRUG DELIVERY SYSTEM; EPIDEMIC ENCEPHALITIS; FLAVIVIRUS; GENE EXPRESSION; GENE SILENCING; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PAPILLOMA VIRUS; PRION DISEASE; PRIORITY JOURNAL; PSEUDOTYPING; REVIEW; RNA INTERFERENCE; RNA PROCESSING; VIRUS ENVELOPE; VIRUS INFECTION;

GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEPATITIS VIRUSES; HIV-1; LENTIVIRUS; MICRORNAS; RNA INTERFERENCE; RNA, SMALL INTERFERING; VIRUS ASSEMBLY;

EID: 67349085202     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2009.03.004     Document Type: Review

References (171)

1. Meister G., and Tuschl T. Mechanisms of gene silencing by double-stranded RNA. Nature 431 (2004) 343-349
2. Hannon G.J., and Rossi J.J. Unlocking the potential of the human genome with RNA interference. Nature 431 (2004) 371-378
3. Matranga C., Tomari Y., Shin C., Bartel D.P., and Zamore P.D. Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes. Cell 123 (2005) 607-620
4. Geiss G., Jin G., Guo J., Bumgarner R., Katze M.G., and Sen G.C. A comprehensive view of regulation of gene expression by double-stranded RNA-mediated cell signaling. J. Biol. Chem. 276 (2001) 30178-30182
5. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., and Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (2001) 494-498
6. Plasterk R.H. RNA silencing: the genome's immune system. Science 296 (2002) 1263-1265
7. Van den Haute C., Eggermont K., Nuttin B., Debyser Z., and Baekelandt V. Lentiviral vector-mediated delivery of short hairpin RNA results in persistent knockdown of gene expression in mouse brain. Hum. Gene Ther. 14 (2003) 1799-1807
8. Lee Y., Jeon K., Lee J.T., Kim S., and Kim V.N. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J. 21 (2002) 4663-4670
9. Lee Y., Ahn C., Han J., Choi H., Kim J., Yim J., Lee J., Provost P., Radmark O., Kim S., and Kim V.N. The nuclear RNase III Drosha initiates microRNA processing. Nature 425 (2003) 415-419
10. Denli A.M., Tops B.B., Plasterk R.H., Ketting R.F., and Hannon G.J. Processing of primary microRNAs by the Microprocessor complex. Nature 432 (2004) 231-235
11. Gregory R.I., Yan K.P., Amuthan G., Chendrimada T., Doratotaj B., Cooch N., and Shiekhattar R. The Microprocessor complex mediates the genesis of microRNAs. Nature 432 (2004) 235-240
12. Landthaler M., Yalcin A., and Tuschl T. The human DiGeorge syndrome critical region gene 8 and its D. melanogaster homolog are required for miRNA biogenesis. Curr. Biol. 14 (2004) 2162-2167
13. Han J., Lee Y., Yeom K.H., Nam J.W., Heo I., Rhee J.K., Sohn S.Y., Cho Y., Zhang B.T., and Kim V.N. Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell 125 (2006) 887-901
14. Yi R., Qin Y., Macara I.G., and Cullen B.R. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 17 (2003) 3011-3016
15. Lund E., Guttinger S., Calado A., Dahlberg J.E., and Kutay U. Nuclear export of microRNA precursors. Science 303 (2004) 95-98
16. Hutvagner G., McLachlan J., Pasquinelli A.E., Balint E., Tuschl T., and Zamore P.D. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293 (2001) 834-838
17. Grishok A., Pasquinelli A.E., Conte D., Li N., Parrish S., Ha I., Baillie D.L., Fire A., Ruvkun G., and Mello C.C. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell 106 (2001) 23-34
18. Ketting R.F., Fischer S.E., Bernstein E., Sijen T., Hannon G.J., and Plasterk R.H. Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes Dev. 15 (2001) 2654-2659
19. Macrae I.J., Zhou K., Li F., Repic A., Brooks A.N., Cande W.Z., Adams P.D., and Doudna J.A. Structural basis for double-stranded RNA processing by Dicer. Science 311 (2006) 195-198
20. Schwarz D.S., Hutvagner G., Du T., Xu Z., Aronin N., and Zamore P.D. Asymmetry in the assembly of the RNAi enzyme complex. Cell 115 (2003) 199-208
21. Chendrimada T.P., Gregory R.I., Kumaraswamy E., Norman J., Cooch N., Nishikura K., and Shiekhattar R. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 436 (2005) 740-744
22. Rand T.A., Petersen S., Du F., and Wang X. Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation. Cell 123 (2005) 621-629
23. Landgraf P., Rusu M., Sheridan R., Sewer A., Iovino N., Aravin A., Pfeffer S., Rice A., Kamphorst A.O., Landthaler M., Lin C., Socci N.D., Hermida L., Fulci V., Chiaretti S., Foa R., Schliwka J., Fuchs U., Novosel A., Muller R.U., Schermer B., Bissels U., Inman J., Phan Q., Chien M., Weir D.B., Choksi R., De Vita G., Frezzetti D., Trompeter H.I., Hornung V., Teng G., Hartmann G., Palkovits M., Di Lauro R., Wernet P., Macino G., Rogler C.E., Nagle J.W., Ju J., Papavasiliou F.N., Benzing T., Lichter P., Tam W., Brownstein M.J., Bosio A., Borkhardt A., Russo J.J., Sander C., Zavolan M., and Tuschl T. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129 (2007) 1401-1414
24. Khvorova A., Reynolds A., and Jayasena S.D. Functional siRNAs and miRNAs exhibit strand bias. Cell 115 (2003) 209-216
25. Ambros V. The functions of animal microRNAs. Nature 431 (2004) 350-355
26. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 (2004) 281-297
27. Lee R.C., Feinbaum R.L., and Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75 (1993) 843-854
28. Wightman B., Ha I., and Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75 (1993) 855-862
29. Lai E.C. Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation. Nat. Genet. 30 (2002) 363-364
30. Lewis B.P., Shih I.H., Jones-Rhoades M.W., Bartel D.P., and Burge C.B. Prediction of mammalian microRNA targets. Cell 115 (2003) 787-798
31. Doench J.G., and Sharp P.A. Specificity of microRNA target selection in translational repression. Genes Dev. 18 (2004) 504-511
32. Lim L.P., Lau N.C., Garrett-Engele P., Grimson A., Schelter J.M., Castle J., Bartel D.P., Linsley P.S., and Johnson J.M. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433 (2005) 769-773
33. Wiznerowicz M., and Trono D. Harnessing HIV for therapy, basic research and biotechnology. Trends Biotechnol. 23 (2005) 42-47
34. Cockrell A.S., and Kafri T. Gene delivery by lentivirus vectors. Mol. Biotechnol. 36 (2007) 184-204
35. Hacein-Bey-Abina S., von Kalle C., Schmidt M., Le Deist F., Wulffraat N., McIntyre E., Radford I., Villeval J.L., Fraser C.C., Cavazzana-Calvo M., and Fischer A. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348 (2003) 255-256
36. Check E. Gene therapy put on hold as third child develops cancer. Nature 433 (2005) 561
37. Hacein-Bey-Abina S., Garrigue A., Wang G.P., Soulier J., Lim A., Morillon E., Clappier E., Caccavelli L., Delabesse E., Beldjord K., Asnafi V., MacIntyre E., Dal Cortivo L., Radford I., Brousse N., Sigaux F., Moshous D., Hauer J., Borkhardt A., Belohradsky B.H., Wintergerst U., Velez M.C., Leiva L., Sorensen R., Wulffraat N., Blanche S., Bushman F.D., Fischer A., and Cavazzana-Calvo M. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J. Clin. Invest. 118 (2008) 3132-3142
38. Schroder A.R., Shinn P., Chen H., Berry C., Ecker J.R., and Bushman F. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110 (2002) 521-529
39. Cattoglio C., Facchini G., Sartori D., Antonelli A., Miccio A., Cassani B., Schmidt M., von Kalle C., Howe S., Thrasher A.J., Aiuti A., Ferrari G., Recchia A., and Mavilio F. Hot spots of retroviral integration in human CD34+ hematopoietic cells. Blood 110 (2007) 1770-1778
40. Levine B.L., Humeau L.M., Boyer J., MacGregor R.R., Rebello T., Lu X., Binder G.K., Slepushkin V., Lemiale F., Mascola J.R., Bushman F.D., Dropulic B., and June C.H. Gene transfer in humans using a conditionally replicating lentiviral vector. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 17372-17377
41. Kotsopoulou E., Kim V.N., Kingsman A.J., Kingsman S.M., and Mitrophanous K.A. A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene. J. Virol. 74 (2000) 4839-4852
42. ter Brake O., Konstantinova P., Ceylan M., and Berkhout B. Silencing of HIV-1 with RNA interference: a multiple shRNA approach. Molec. Ther. 14 (2006) 883-892
43. Kappes J.C., Wu X., and Wakefield J.K. Production of trans-lentiviral vector with predictable safety. Methods Mol. Med. 76 (2003) 449-465
44. Philpott N.J., and Thrasher A.J. Use of nonintegrating lentiviral vectors for gene therapy. Hum. Gene Ther. 18 (2007) 483-489
45. Themis M., Waddington S.N., Schmidt M., von Kalle C., Wang Y., Al-Allaf F., Gregory L.G., Nivsarkar M., Holder M.V., Buckley S.M., Dighe N., Ruthe A.T., Mistry A., Bigger B., Rahim A., Nguyen T.H., Trono D., Thrasher A.J., and Coutelle C. Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice. Molec. Ther. 12 (2005) 763-771
46. Kingsman S.M., Mitrophanous K., and Olsen J.C. Potential oncogene activity of the woodchuck hepatitis post-transcriptional regulatory element (WPRE). Gene Ther. 12 (2005) 3-4
47. Schambach A., Bohne J., Baum C., Hermann F.G., Egerer L., von Laer D., and Giroglou T. Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression. Gene Ther. 13 (2006) 641-645
48. Miyoshi H., Blomer U., Takahashi M., Gage F.H., and Verma I.M. Development of a self-inactivating lentivirus vector. J. Virol. 72 (1998) 8150-8157
49. Aiken C. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. J. Virol. 71 (1997) 5871-5877
50. Croyle M.A., Callahan S.M., Auricchio A., Schumer G., Linse K.D., Wilson J.M., Brunner L.J., and Kobinger G.P. PEGylation of a vesicular stomatitis virus G pseudotyped lentivirus vector prevents inactivation in serum. J. Virol. 78 (2004) 912-921
51. Manjunath N., Kumar P., Lee S.K., and Shankar P. Interfering antiviral immunity: application, subversion, hope?. Trends Immunol. 27 (2006) 328-335
52. Cronin J., Zhang X.Y., and Reiser J. Altering the tropism of lentiviral vectors through pseudotyping. Curr. Gene Ther. 5 (2005) 387-398
53. Wong L.F., Azzouz M., Walmsley L.E., Askham Z., Wilkes F.J., Mitrophanous K.A., Kingsman S.M., and Mazarakis N.D. Transduction patterns of pseudotyped lentiviral vectors in the nervous system. Molec. Ther. 9 (2004) 101-111
54. Kumar P., Wu H., McBride J.L., Jung K.E., Kim M.H., Davidson B.L., Lee S.K., Shankar P., and Manjunath N. Transvascular delivery of small interfering RNA to the central nervous system. Nature 448 (2007) 39-43
55. Morizono K., Bristol G., Xie Y.M., Kung S.K., and Chen I.S. Antibody-directed targeting of retroviral vectors via cell surface antigens. J. Virol. 75 (2001) 8016-8020
56. Morizono K., Xie Y., Ringpis G.E., Johnson M., Nassanian H., Lee B., Wu L., and Chen I.S. Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection. Nat. Med. 11 (2005) 346-352
57. Pariente N., Mao S.H., Morizono K., and Chen I.S. Efficient targeted transduction of primary human endothelial cells with dual-targeted lentiviral vectors. J. Gene Med. 10 (2008) 242-248
58. Pariente N., Morizono K., Virk M.S., Petrigliano F.A., Reiter R.E., Lieberman J.R., and Chen I.S. A novel dual-targeted lentiviral vector leads to specific transduction of prostate cancer bone metastases in vivo after systemic administration. Mol. Ther. 15 (2007) 1973-1981
59. Ziegler L., Yang L., Joo K., Yang H., Baltimore D., and Wang P. Targeting lentiviral vectors to antigen-specific immunoglobulins. Hum. Gene Ther. 19 (2008) 861-872
60. Yang L., Yang H., Rideout K., Cho T., Joo K.I., Ziegler L., Elliot A., Walls A., Yu D., Baltimore D., and Wang P. Engineered lentivector targeting of dendritic cells for in vivo immunization. Nat. Biotechnol. 26 (2008) 326-334
61. Sioud M. Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization. J. Mol. Biol. 348 (2005) 1079-1090
62. Hornung V., Guenthner-Biller M., Bourquin C., Ablasser A., Schlee M., Uematsu S., Noronha A., Manoharan M., Akira S., de Fougerolles A., Endres S., and Hartmann G. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med. 11 (2005) 263-270
63. Judge A.D., Sood V., Shaw J.R., Fang D., McClintock K., and MacLachlan I. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat. Biotechnol. 23 (2005) 457-462
64. Grimm D., Streetz K.L., Jopling C.L., Storm T.A., Pandey K., Davis C.R., Marion P., Salazar F., and Kay M.A. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 441 (2006) 537-541
65. Yi R., Doehle B.P., Qin Y., Macara I.G., and Cullen B.R. Overexpression of exportin 5 enhances RNA interference mediated by short hairpin RNAs and microRNAs. RNA 11 (2005) 220-226
66. Boudreau R.L., Monteys A.M., and Davidson B.L. Minimizing variables among hairpin-based RNAi vectors reveals the potency of shRNAs. RNA 14 (2008) 1834-1844
67. An D.S., Qin F.X., Auyeung V.C., Mao S.H., Kung S.K., Baltimore D., and Chen I.S. Optimization and functional effects of stable short hairpin RNA expression in primary human lymphocytes via lentiviral vectors. Mol. Ther. 14 (2006) 494-504
68. Dykxhoorn D.M., Novina C.D., and Sharp P.A. Killing the messenger: short RNAs that silence gene expression. Nat. Rev., Mol. Cell Biol. 4 (2003) 457-467
69. Mittal V. Improving the efficiency of RNA interference in mammals. Nat. Rev. Genet. 5 (2004) 355-365
70. Kim D.H., and Rossi J.J. Coupling of RNAi-mediated target downregulation with gene replacement. Antisense Nucleic Acid Drug Dev. 13 (2003) 151-155
71. Hornung V., Ellegast J., Kim S., Brzozka K., Jung A., Kato H., Poeck H., Akira S., Conzelmann K.K., Schlee M., Endres S., and Hartmann G. 5′-Triphosphate RNA is the ligand for RIG-I. Science 314 (2006) 994-997
72. Pichlmair A., Schulz O., Tan C.P., Naslund T.I., Liljestrom P., Weber F., and Reis e Sousa C. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314 (2006) 997-1001
73. Scherer L.J., Frank R., and Rossi J.J. Optimization and characterization of tRNA-shRNA expression constructs. Nucleic Acids Res. 35 (2007) 2620-2628
74. Zhang H., Kolb F.A., Brondani V., Billy E., and Filipowicz W. Human Dicer preferentially cleaves dsRNAs at their termini without a requirement for ATP. EMBO J. 21 (2002) 5875-5885
75. Zhang H., Kolb F.A., Jaskiewicz L., Westhof E., and Filipowicz W. Single processing center models for human Dicer and bacterial RNase III. Cell 118 (2004) 57-68
76. Paddison P.J., Caudy A.A., Bernstein E., Hannon G.J., and Conklin D.S. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev. 16 (2002) 948-958
77. Zeng Y., Wagner E.J., and Cullen B.R. Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol. Cell 9 (2002) 1327-1333
78. Chen C.Z., Li L., Lodish H.F., and Bartel D.P. MicroRNAs modulate hematopoietic lineage differentiation. Science 303 (2004) 83-86
79. Zeng Y., Yi R., and Cullen B.R. Recognition and cleavage of primary microRNA precursors by the nuclear processing enzyme Drosha. EMBO J. 24 (2005) 138-148
80. Chang K., Elledge S.J., and Hannon G.J. Lessons from nature: microRNA-based shRNA libraries. Nat. Methods 3 (2006) 707-714
81. Silva J.M., Li M.Z., Chang K., Ge W., Golding M.C., Rickles R.J., Siolas D., Hu G., Paddison P.J., Schlabach M.R., Sheth N., Bradshaw J., Burchard J., Kulkarni A., Cavet G., Sachidanandam R., McCombie W.R., Cleary M.A., Elledge S.J., and Hannon G.J. Second-generation shRNA libraries covering the mouse and human genomes. Nat. Genet. 37 (2005) 1281-1288
82. Stegmeier F., Hu G., Rickles R.J., Hannon G.J., and Elledge S.J. A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 13212-13217
83. Ruby J.G., Jan C., Player C., Axtell M.J., Lee W., Nusbaum C., Ge H., and Bartel D.P. Large-scale sequencing reveals 21U-RNAs and additional microRNAs and endogenous siRNAs in C. elegans. Cell 127 (2006) 1193-1207
84. Seitz H., Ghildiyal M., and Zamore P.D. Argonaute loading improves the 5′ precision of both microRNAs and their miRNA strands in flies. Curr. Biol. 18 (2008) 147-151
85. Wu H., Neilson J.R., Kumar P., Manocha M., Shankar P., Sharp P.A., and Manjunath N. miRNA profiling of naive, effector and memory CD8 T cells. PLoS ONE 2 (2007) e1020
86. Piskounova E., Viswanathan S.R., Janas M., Lapierre R.J., Daley G.Q., Sliz P., and Gregory R.I. Determinants of microRNA processing inhibition by the developmentally regulated RNA-binding protein Lin28. J. Biol. Chem. 283 31 (2008) 21310-21314 Electronic publication ahead of print 2008 Jun 12
87. Newman M.A., Thomson J.M., and Hammond S.M. Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing. RNA 14 (2008) 1539-1549
88. Viswanathan S.R., Daley G.Q., and Gregory R.I. Selective blockade of microRNA processing by Lin28. Science 320 (2008) 97-100
89. McBride J.L., Boudreau R.L., Harper S.Q., Staber P.D., Monteys A.M., Martins I., Gilmore B.L., Burstein H., Peluso R.W., Polisky B., Carter B.J., and Davidson B.L. Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 5868-5873
90. Boden D., Pusch O., Lee F., Tucker L., and Ramratnam B. Human immunodeficiency virus type 1 escape from RNA interference. J. Virol. 77 (2003) 11531-11535
91. Das A.T., Brummelkamp T.R., Westerhout E.M., Vink M., Madiredjo M., Bernards R., and Berkhout B. Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J. Virol. 78 (2004) 2601-2605
92. Westerhout E.M., Ooms M., Vink M., Das A.T., and Berkhout B. HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res. 33 (2005) 796-804
93. Akashi H., Miyagishi M., Yokota T., Watanabe T., Hino T., Nishina K., Kohara M., and Taira K. Escape from the interferon response associated with RNA interference using vectors that encode long modified hairpin-RNA. Mol. Biosyst. 1 (2005) 382-390
94. Konstantinova P., ter Brake O., Haasnoot J., de Haan P., and Berkhout B. Trans-inhibition of HIV-1 by a long hairpin RNA expressed within the viral genome. Retrovirology 4 (2007) 15
95. Sano M., Li H., Nakanishi M., and Rossi J.J. Expression of long anti-HIV-1 hairpin RNAs for the generation of multiple siRNAs: advantages and limitations. Molec. Ther. 16 (2008) 170-177
96. Watanabe T., Sudoh M., Miyagishi M., Akashi H., Arai M., Inoue K., Taira K., Yoshiba M., and Kohara M. Intracellular-diced dsRNA has enhanced efficacy for silencing HCV RNA and overcomes variation in the viral genotype. Gene Ther. 13 (2006) 883-892
97. Weinberg M.S., Ely A., Barichievy S., Crowther C., Mufamadi S., Carmona S., and Arbuthnot P. Specific inhibition of HBV replication in vitro and in vivo with expressed long hairpin RNA. Molec. Ther. 15 (2007) 534-541
98. Henry S.D., van der Wegen P., Metselaar H.J., Tilanus H.W., Scholte B.J., and van der Laan L.J. Simultaneous targeting of HCV replication and viral binding with a single lentiviral vector containing multiple RNA interference expression cassettes. Molec. Ther. 14 (2006) 485-493
99. Anderson J., and Akkina R. CXCR4 and CCR5 shRNA transgenic CD34+ cell derived macrophages are functionally normal and resist HIV-1 infection. Retrovirology 2 (2005) 53
100. ter Brake O., t Hooft K., Liu Y.P., Centlivre M., von Eije K.J., and Berkhout B. Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition. Molec. Ther. 16 (2008) 557-564
101. Gou D., Weng T., Wang Y., Wang Z., Zhang H., Gao L., Chen Z., Wang P., and Liu L. A novel approach for the construction of multiple shRNA expression vectors. J. Gene Med. 9 (2007) 751-763
102. Li M.J., Kim J., Li S., Zaia J., Yee J.K., Anderson J., Akkina R., and Rossi J.J. Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy. Molec. Ther. 12 (2005) 900-909
103. Anderson J., Li M.J., Palmer B., Remling L., Li S., Yam P., Yee J.K., Rossi J., Zaia J., and Akkina R. Safety and efficacy of a lentiviral vector containing three anti-HIV genes-CCR5 ribozyme, tat-rev siRNA, and TAR decoy-in SCID-hu mouse-derived T cells. Molec. Ther. 15 (2007) 1182-1188
104. Liu Y.P., Haasnoot J., ter Brake O., Berkhout B., and Konstantinova P. Inhibition of HIV-1 by multiple siRNAs expressed from a single microRNA polycistron. Nucleic Acids Res. 36 (2008) 2811-2824
105. Aagaard L.A., Zhang J., von Eije K.J., Li H., Saetrom P., Amarzguioui M., and Rossi J.J. Engineering and optimization of the miR-106b cluster for ectopic expression of multiplexed anti-HIV RNAs. Gene Ther. 15 (2008) 1536-1549
106. Wiznerowicz M., Szulc J., and Trono D. Tuning silence: conditional systems for RNA interference. Nat. Methods 3 (2006) 682-688
107. Pluta K., Diehl W., Zhang X.Y., Kutner R., Bialkowska A., and Reiser J. Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study. BMC Biotechnol. 7 (2007) 41
108. Amar L., Desclaux M., Faucon-Biguet N., Mallet J., and Vogel R. Control of small inhibitory RNA levels and RNA interference by doxycycline induced activation of a minimal RNA polymerase III promoter. Nucleic Acids Res. 34 (2006) e37
109. Szulc J., Wiznerowicz M., Sauvain M.O., Trono D., and Aebischer P. A versatile tool for conditional gene expression and knockdown. Nat. Methods 3 (2006) 109-116
110. Miyagishi M., Sumimoto H., Miyoshi H., Kawakami Y., and Taira K. Optimization of an siRNA-expression system with an improved hairpin and its significant suppressive effects in mammalian cells. J. Gene Med. 6 (2004) 715-723
111. Gupta S., Schoer R.A., Egan J.E., Hannon G.J., and Mittal V. Inducible, reversible, and stable RNA interference in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 1927-1932
112. Wiznerowicz M., and Trono D. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J. Virol. 77 (2003) 8957-8961
113. Shin K.J., Wall E.A., Zavzavadjian J.R., Santat L.A., Liu J., Hwang J.I., Rebres R., Roach T., Seaman W., Simon M.I., and Fraser I.D. A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 13759-13764
114. Aagaard L., Amarzguioui M., Sun G., Santos L.C., Ehsani A., Prydz H., and Rossi J.J. A facile lentiviral vector system for expression of doxycycline-inducible shRNAs: knockdown of the pre-miRNA processing enzyme Drosha. Molec. Ther. 15 (2007) 938-945
115. Herold M.J., van den Brandt J., Seibler J., and Reichardt H.M. Inducible and reversible gene silencing by stable integration of an shRNA-encoding lentivirus in transgenic rats. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 18507-18512
116. Unwalla H.J., Li M.J., Kim J.D., Li H.T., Ehsani A., Alluin J., and Rossi J.J. Negative feedback inhibition of HIV-1 by TAT-inducible expression of siRNA. Nat. Biotechnol. 22 (2004) 1573-1578
117. Westerhout E.M., Vink M., Haasnoot P.C., Das A.T., and Berkhout B. A conditionally replicating HIV-based vector that stably expresses an antiviral shRNA against HIV-1 replication. Molec. Ther. 14 (2006) 268-275
118. Shukla V., Coumoul X., and Deng C.X. RNAi-based conditional gene knockdown in mice using a U6 promoter driven vector. Int. J. Biol. Sci. 3 (2007) 91-99
119. Yu J., and McMahon A.P. Reproducible and inducible knockdown of gene expression in mice. Genesis 44 (2006) 252-261
120. Ventura A., Meissner A., Dillon C.P., McManus M., Sharp P.A., Van Parijs L., Jaenisch R., and Jacks T. Cre-lox-regulated conditional RNA interference from transgenes. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 10380-10385
121. Iovino N., Denti M.A., Bozzoni I., and Cortese R. A loxP-containing pol II promoter for RNA interference is reversibly regulated by Cre recombinase. RNA Biol. 2 (2005) 86-92
122. Hitz C., Wurst W., and Kuhn R. Conditional brain-specific knockdown of MAPK using Cre/loxP regulated RNA interference. Nucleic Acids Res. 35 (2007) e90
123. Kasim V., Miyagishi M., and Taira K. Control of siRNA expression using the Cre-loxP recombination system. Nucleic Acids Res. 32 (2004) e66
124. Fritsch L., Martinez L.A., Sekhri R., Naguibneva I., Gerard M., Vandromme M., Schaeffer L., and Harel-Bellan A. Conditional gene knock-down by CRE-dependent short interfering RNAs. EMBO Rep. 5 (2004) 178-182
125. Steuber-Buchberger P., Wurst W., and Kuhn R. Simultaneous Cre-mediated conditional knockdown of two genes in mice. Genesis 46 (2008) 144-151
126. Stern P., Astrof S., Erkeland S.J., Schustak J., Sharp P.A., and Hynes R.O. A system for Cre-regulated RNA interference in vivo. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 13895-13900
127. Dykxhoorn D.M., Chowdhury D., and Lieberman J. RNA interference and cancer: endogenous pathways and therapeutic approaches. Adv. Exp. Med. Biol. 615 (2008) 299-329
128. Sumimoto H., and Kawakami Y. Lentiviral vector-mediated RNAi and its use for cancer research. Future Oncol. 3 (2007) 655-664
129. Putral L.N., Gu W., and McMillan N.A. RNA interference for the treatment of cancer. Drug News Perspect. 19 (2006) 317-324
130. Farah M.H. RNAi silencing in mouse models of neurodegenerative diseases. Curr. Drug Deliv. 4 (2007) 161-167
131. Boudreau R.L., and Davidson B.L. RNAi therapy for neurodegenerative diseases. Curr. Top. Dev. Biol. 75 (2006) 73-92
132. Wong L.F., Goodhead L., Prat C., Mitrophanous K.A., Kingsman S.M., and Mazarakis N.D. Lentivirus-mediated gene transfer to the central nervous system: therapeutic and research applications. Hum. Gene Ther. 17 (2006) 1-9
133. ter Brake O., and Berkhout B. Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions. J. Gene Med. 9 (2007) 743-750
134. Capodici J., Kariko K., and Weissman D. Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference. J. Immunol. 169 (2002) 5196-5201
135. Hu W.Y., Myers C.P., Kilzer J.M., Pfaff S.L., and Bushman F.D. Inhibition of retroviral pathogenesis by RNA interference. Curr. Biol. 12 (2002) 1301-1311
136. Surabhi R.M., and Gaynor R.B. RNA interference directed against viral and cellular targets inhibits human immunodeficiency virus type 1 replication. J. Virol. 76 (2002) 12963-12973
137. Stebbing J., and Moyle G. The clades of HIV: their origins and clinical significance. AIDS Rev. 5 (2003) 205-213
138. Bello G., Casado C., Garcia S., Rodriguez C., del Romero J., and Lopez-Galindez C. Co-existence of recent and ancestral nucleotide sequences in viral quasispecies of human immunodeficiency virus type 1 patients. J. Gen. Virol. 85 (2004) 399-407
139. Ahumada-Ruiz S., Casado C., Toala-Gonzalez I., Flores-Figueroa D., Rodriguez-French A., and Lopez-Galindez C. High divergence within the major HIV type 1 subtype B epidemic in Panama. AIDS Res. Hum. Retrovir. 24 (2008) 1461-1466
140. von Eije K.J., ter Brake O., and Berkhout B. Human immunodeficiency virus type 1 escape is restricted when conserved genome sequences are targeted by RNA interference. J. Virol. 82 (2008) 2895-2903
141. Chang L.J., Liu X., and He J. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1. Gene Ther. 12 (2005) 1133-1144
142. Han W., Wind-Rotolo M., Kirkman R.L., and Morrow C.D. Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site. Virology 330 (2004) 221-232
143. Dave R.S., and Pomerantz R.J. Antiviral effects of human immunodeficiency virus type 1-specific small interfering RNAs against targets conserved in select neurotropic viral strains. J. Virol. 78 (2004) 13687-13696
144. Lee S.K., Dykxhoorn D.M., Kumar P., Ranjbar S., Song E., Maliszewski L.E., Francois-Bongarcon V., Goldfeld A., Swamy N.M., Lieberman J., and Shankar P. Lentiviral delivery of short hairpin RNAs protects CD4 T cells from multiple clades and primary isolates of HIV. Blood 106 (2005) 818-826
145. Samson M., Libert F., Doranz B.J., Rucker J., Liesnard C., Farber C.M., Saragosti S., Lapoumeroulie C., Cognaux J., Forceille C., Muyldermans G., Verhofstede C., Burtonboy G., Georges M., Imai T., Rana S., Yi Y., Smyth R.J., Collman R.G., Doms R.W., Vassart G., and Parmentier M. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382 (1996) 722-725
146. Huang Y., Paxton W.A., Wolinsky S.M., Neumann A.U., Zhang L., He T., Kang S., Ceradini D., Jin Z., Yazdanbakhsh K., Kunstman K., Erickson D., Dragon E., Landau N.R., Phair J., Ho D.D., and Koup R.A. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat. Med. 2 (1996) 1240-1243
147. Qin X.F., An D.S., Chen I.S., and Baltimore D. Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 183-188
148. Lee M.T., Coburn G.A., McClure M.O., and Cullen B.R. Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat- or CCR5-specific small interfering RNAs expressed from a lentivirus vector. J. Virol. 77 (2003) 11964-11972
149. Butticaz C., Ciuffi A., Munoz M., Thomas J., Bridge A., Pebernard S., Iggo R., Meylan P., and Telenti A. Protection from HIV-1 infection of primary CD4 T cells by CCR5 silencing is effective for the full spectrum of CCR5 expression. Antivir. Ther. 8 (2003) 373-377
150. Brass A.L., Dykxhoorn D.M., Benita Y., Yan N., Engelman A., Xavier R.J., Lieberman J., and Elledge S.J. Identification of host proteins required for HIV infection through a functional genomic screen. Science 319 (2008) 921-926
151. Lo H.L., Chang T., Yam P., Marcovecchio P.M., Li S., Zaia J.A., and Yee J.K. Inhibition of HIV-1 replication with designed miRNAs expressed from RNA polymerase II promoters. Gene Ther. 14 (2007) 1503-1512
152. Strayer D.S., Akkina R., Bunnell B.A., Dropulic B., Planelles V., Pomerantz R.J., Rossi J.J., and Zaia J.A. Current status of gene therapy strategies to treat HIV/AIDS. Molec. Ther. 11 (2005) 823-842
153. Banerjea A., Li M.J., Bauer G., Remling L., Lee N.S., Rossi J., and Akkina R. Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in T lymphocytes differentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages. Molec. Ther. 8 (2003) 62-71
154. Li M., and Rossi J.J. Lentiviral vector delivery of siRNA and shRNA encoding genes into cultured and primary hematopoietic cells. Methods Mol. Biol. 309 (2005) 261-272
155. An D.S., Donahue R.E., Kamata M., Poon B., Metzger M., Mao S.H., Bonifacino A., Krouse A.E., Darlix J.L., Baltimore D., Qin F.X., and Chen I.S. Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 13110-13115
156. Arbuthnot P., and Thompson L.J. Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma. World J. Gastroenterol. 14 (2008) 1670-1681
157. Chen Y., Cheng G., and Mahato R.I. RNAi for treating hepatitis B viral infection. Pharm. Res. 25 (2008) 72-86
158. Ma Y., Chan C.Y., and He M.L. RNA interference and antiviral therapy. World J. Gastroenterol. 13 (2007) 5169-5179
159. Gu W., Putral L., and McMillan N. siRNA and shRNA as anticancer agents in a cervical cancer model. Methods Mol. Biol. 442 (2008) 159-172
160. Gu W., Putral L., Hengst K., Minto K., Saunders N.A., Leggatt G., and McMillan N.A. Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes. Cancer Gene Ther. 13 (2006) 1023-1032
161. Bai L., Wei L., Wang J., Li X., and He P. Extended effects of human papillomavirus 16 E6-specific short hairpin RNA on cervical carcinoma cells. Int. J. Gynecol. Cancer 16 (2006) 718-729
162. Putral L.N., Bywater M.J., Gu W., Saunders N.A., Gabrielli B.G., Leggatt G.R., and McMillan N.A. RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin. Mol. Pharmacol. 68 (2005) 1311-1319
163. Fechner H., Sipo I., Westermann D., Pinkert S., Wang X., Suckau L., Kurreck J., Zeichhardt H., Muller O., Vetter R., Erdmann V., Tschope C., and Poller W. Cardiac-targeted RNA interference mediated by an AAV9 vector improves cardiac function in coxsackievirus B3 cardiomyopathy. J. Mol. Med. 86 (2008) 987-997
164. Kim Y.J., Ahn J., Jeung S.Y., Kim D.S., Na H.N., Cho Y.J., Yun S.H., Jee Y., Jeon E.S., Lee H., and Nam J.H. Recombinant lentivirus-delivered short hairpin RNAs targeted to conserved coxsackievirus sequences protect against viral myocarditis and improve survival rate in an animal model. Virus Genes 36 (2008) 141-146
165. Fechner H., Pinkert S., Wang X., Sipo I., Suckau L., Kurreck J., Dorner A., Sollerbrant K., Zeichhardt H., Grunert H.P., Vetter R., Schultheiss H.P., and Poller W. Coxsackievirus B3 and adenovirus infections of cardiac cells are efficiently inhibited by vector-mediated RNA interference targeting their common receptor. Gene Ther. 14 (2007) 960-971
166. Kim J.Y., Chung S.K., Hwang H.Y., Kim H., Kim J.H., Nam J.H., and Park S.I. Expression of short hairpin RNAs against the coxsackievirus B3 exerts potential antiviral effects in Cos-7 cells and in mice. Virus Res. 125 (2007) 9-13
167. Kumar P., Lee S.K., Shankar P., and Manjunath N. A single siRNA suppresses fatal encephalitis induced by two different flaviviruses. PLoS Med. 3 (2006) e96
168. White M.D., Farmer M., Mirabile I., Brandner S., Collinge J., and Mallucci G.R. Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 10238-10243
169. Pfeifer A., Eigenbrod S., Al-Khadra S., Hofmann A., Mitteregger G., Moser M., Bertsch U., and Kretzschmar H. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice. J. Clin. Invest. 116 (2006) 3204-3210
170. Castanotto D., and Rossi J.J. The promises and pitfalls of RNA-interference-based therapeutics. Nature 457 (2009) 426-433
171. Kumar P., Ban H.S., Kim S.S., Wu H., Pearson T., Greiner D.L., Laouar A., Yao J., Haridas V., Habiro K., Yang Y.G., Jeong J.H., Lee K.Y., Kim Y.H., Kim S.W., Peipp M., Fey G.H., Manjunath N., Shultz L.D., Lee S.K., and Shankar P. T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell 134 (2008) 577-586